Results 111 to 120 of about 7,735 (212)

C-terminal dimerization motifs control asynchronous chain elongation during modular polyketide biosynthesis. [PDF]

J Biol Chem
Liu C, West RC, Chen M, Cohn W, Wang G, Kim S, Mandot AM, Faull KF, Cogan DP.   +8 more
europepmc   +1 more source

Salinirifamycins A-E: Rifamycin S Derivatives from the Brazilian Marine Actinomycete Salinispora arenicola. [PDF]

J Nat Prod
Batista da Silva A, Pinto FCL, Silveira ER, Paulo TF, Wilke DV, Ferreira EG, Costa-Lotufo LV, Canuto KM, Marinho-Filho JDB, Barros AB, Nuzzo G, Fontana A, Monteiro NKV, Pessoa ODL.   +13 more
europepmc   +1 more source

Infectious Disease Management in Resource-Limited Settings. [PDF]

Open Forum Infect Dis
Seas C.
europepmc   +1 more source

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source

New Structure Activity Relationship Insight into the Role of the C-3 Extension on Rifamycin Antimycobacterial Activity. [PDF]

ChemMedChem
Veale CGL, Smolarz E, Leśniewska A, Pyta K, Przybylski P.   +4 more
europepmc   +1 more source

Comparative efficacy and safety of high-dose rifamycin regimens for tuberculosis treatment: a Bayesian network meta-analysis. [PDF]

BMJ Open
Feng Z, Wu H, Li Q, Zhang X, He Q, Wang H, Yu J, Ge S, Song L, Zhang Y, Zhou X, Sun F, Zhang J, Li Y, Zhang W.   +14 more
europepmc   +1 more source

Pharmacokinetic Interaction Between Isavuconazole and Rifabutin in a Real-World Setting. [PDF]

Mycoses
Shah S, Clarke L, Lee T, Georgiades L, Smith BJ, Venkataramanan R, Rivosecchi RM.   +6 more
europepmc   +1 more source

Flavin-dependent monooxygenases as versatile biocatalysts in biomanufacturing: mechanisms, engineering, and applications. [PDF]

Biotechnol Biofuels Bioprod
Li Y, Zhao L, Pu X, Geng B, Liu W, Gao J, Peng X, Han Y.   +7 more
europepmc   +1 more source

Dietary allyl-isothiocyanate affects male triglyceride levels in <i>Drosophila melanogaster</i> without detectable changes in microbiota composition. [PDF]

Front Microbiol
Dähn S, Hurka S, Kreft D, Guzman J, Poehlein A, Vilcinskas A, Tegtmeier D, Wagner AE.   +7 more
europepmc   +1 more source

Proteomic Insights into Antimicrobial Resistance Mechanisms in Human-Associated Bacterial Pathogens. [PDF]

Microb Ecol
Babele P, Singh P, Pant A, Chawla M, Das B.   +4 more
europepmc   +1 more source